Terms: = Kidney tumors AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Treatment
15 results:
1. HES1-mediated down-regulation of miR-138 sustains notch1 activation and promotes proliferation and invasion in renal cell carcinoma.
Liu S; Dou L; Miao M; Man X; Wei B; Jiang Z; Ouyang Y; Ozaki T; Yu M; Zhu Y
J Exp Clin Cancer Res; 2023 Mar; 42(1):72. PubMed ID: 36973704
[TBL] [Abstract] [Full Text] [Related]
2. Selenite Inhibits Notch Signaling in Cells and Mice.
Powers M; Liu L; Deemer D; Chen S; Scholl A; Yoshinaga M; Liu Z
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802299
[TBL] [Abstract] [Full Text] [Related]
3. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer.
Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J
J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657
[TBL] [Abstract] [Full Text] [Related]
4. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract] [Full Text] [Related]
5. Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.
Bhagat TD; Zou Y; Huang S; Park J; Palmer MB; Hu C; Li W; Shenoy N; Giricz O; Choudhary G; Yu Y; Ko YA; Izquierdo MC; Park AS; Vallumsetla N; Laurence R; Lopez R; Suzuki M; Pullman J; Kaner J; Gartrell B; Hakimi AA; Greally JM; Patel B; Benhadji K; Pradhan K; Verma A; Susztak K
J Biol Chem; 2017 Jan; 292(3):837-846. PubMed ID: 27909050
[TBL] [Abstract] [Full Text] [Related]
6. Cantharidin induces G2/M arrest and triggers apoptosis in renal cell carcinoma.
Ren Y; Zhang SW; Xie ZH; Xu XM; Chen LL; Lou ZG; Weng GB; Yao XP
Mol Med Rep; 2016 Dec; 14(6):5614-5618. PubMed ID: 27878266
[TBL] [Abstract] [Full Text] [Related]
7. Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma.
Rini BI; Tomita Y; Melichar B; Ueda T; Grünwald V; Fishman MN; Uemura H; Oya M; Bair AH; Andrews GI; Rosbrook B; Jonasch E
Clin Genitourin Cancer; 2016 Dec; 14(6):499-503. PubMed ID: 27236772
[TBL] [Abstract] [Full Text] [Related]
8. Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk.
Thounaojam MC; Dudimah DF; Pellom ST; Uzhachenko RV; Carbone DP; Dikov MM; Shanker A
Oncotarget; 2015 Oct; 6(32):32439-55. PubMed ID: 26431276
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of γ-secretase by retinoic acid chalcone (RAC) induces G2/M arrest and triggers apoptosis in renal cell carcinoma.
Li QC; Li HJ; Liu S; Liang Y; Wang X; Cui L
Int J Clin Exp Pathol; 2015; 8(3):2400-7. PubMed ID: 26045747
[TBL] [Abstract] [Full Text] [Related]
10. Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: a Southern China Urology Cancer Consortium Trial.
Xie M; He CS; Huang JK; Lin QZ
Eur J Cancer; 2015 Mar; 51(5):595-603. PubMed ID: 25618828
[TBL] [Abstract] [Full Text] [Related]
11. A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
So JY; Lin JJ; Wahler J; Liby KT; Sporn MB; Suh N
PLoS One; 2014; 9(9):e107616. PubMed ID: 25229616
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of γ-secretase in renal carcinoma.
Guo Z; Jin X; Jia H
J Exp Clin Cancer Res; 2013 May; 32(1):26. PubMed ID: 23659326
[TBL] [Abstract] [Full Text] [Related]
13. Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma: When is the revolution coming?
Santoni M; Rizzo M; Burattini L; Berardi R; Carteni G; Cascinu S
Curr Cancer Drug Targets; 2013 Mar; 13(3):313-25. PubMed ID: 23190497
[TBL] [Abstract] [Full Text] [Related]
14. Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis.
Fan RH; Li J; Wu N; Chen PS
World J Gastroenterol; 2011 Aug; 17(29):3420-30. PubMed ID: 21876634
[TBL] [Abstract] [Full Text] [Related]
15. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.
Sjölund J; Johansson M; Manna S; Norin C; Pietras A; Beckman S; Nilsson E; Ljungberg B; Axelson H
J Clin Invest; 2008 Jan; 118(1):217-28. PubMed ID: 18079963
[TBL] [Abstract] [Full Text] [Related]
